Sentences with phrase «cancer tests improve»

Not exact matches

New startup Grail is in the midst of developing a blood test that can detect cancer before its symptoms manifest, which drastically improves the chances of successful treatment.

New York, Wall Street Journal — Genomic Health Inc. has struck a deal to commercialize a new blood test that can help advanced prostate cancer patients decide whether to try costly new - generation drugs or rely on much cheaper traditional chemotherapy to improve their chances for survival.

There is at least one approved device and scores of experimental treatments being tested that could improve the odds of longer - term survival for patients with the type of extremely aggressive brain cancer afflicting U.S. Sen. John McCain.

Nanophotonics research by materials scientist Jennifer Dionne could lead to improved drugs, cancer tests or invisibility cloaks.

In October Anil Potti of Duke University reported that new tests can dramatically improve the odds of choosing the right drugs for a particular patient's cancer.

Clinical trials testing various cancer vaccines have failed miserably; in one, a melanoma vaccine called Canvaxin did not improve the survival of patients, an outcome that ultimately forced the drugmaker to sell itself to another firm.

«Minimally invasive molecular testing for thyroid cancer has improved by leaps and bounds in the last several years,» said co-author Robert L. Ferris, M.D., Ph.D., professor and chief of the Division of Head and Neck Surgery in Pitt's School of Medicine.

Ultrasensitive blood tests known as liquid biopsies promise to improve cancer diagnosis and care

This improves on current screening methods: A Lancet study last year showed that in 108 patients, the immune sequencing test could spot signs of relapse three to five months, on average, before the cancer was visible on a CT scan.

The test can help patients and their doctors to be more vigilant about screenings, potentially catching cancers at their earliest and more treatable stages, and to make more informed decisions about therapies that may improve survival and quality of life.

Now, the University of Michigan Health System has begun offering a new urine test called Mi - Prostate Score to improve on PSA screening for prostate cancer.

«We hope that our test will significantly improve the odds of survival of breast cancer patients by allowing doctors to identify the most effective but least toxic form of chemotherapy for each individual patient before the treatment begins.»

«Improving breast cancer chemo by testing patient's tumors in a dish.»

A test based on the genetic make - up of the Barrett's lesions could benefit patients through improved diagnosis, giving people at high risk of cancer the best care, and reducing the burden of endoscopy for those at low risk.

St. Jude LIFE brings survivors back to the hospital for a battery of tests to evaluate health, functioning and other factors with the goal of improving the lives of current and future pediatric cancer survivors.

If we are able to refine a test to diagnose lung cancer by measuring breath temperature, we will improve the diagnostic process by providing patients with a stress - free and simple test that is also cheaper and less intensive for clinicians.»

Testing for the EGFR mutation and ALK rearrangements and the use of targeted therapies have given lung cancer patients the chance for survival, along with improved quality of life and time with loved ones.

He believes that as our understanding of cancer biology improves, we will use cancer tests more judiciously — and treat less.

Most cancers are curable if they are detected early, and the researchers are exploring ways to use cancer gene discoveries to develop cancer screening tests to improve cancer survival.

Even if blood tests could someday detect pancreatic cancer at an early stage, treatment would have to improve a lot for them to do much good.

Our data pinpoints the need for refined methods for PSA testing and improved prostate cancer treatment strategies,» concludes dr Stattin.

They further tested this ability through a series of experiments to explore what signal may alert radiologists to the presence of a possible abnormality, in the hopes of using these insights to improve breast cancer screening and early detection.

An interactive, practice - focused workshop for primary care providers that improves clinical skills in assessing genetic risk for cancer, ordering and interpreting genetic testing and managing patients at increased risk for cancer.

A new urine - based test improved prostate cancer detection — including detecting more aggressive forms of prostate cancer — compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.

The goal is to improve the understanding of biological basis of cancer, to address the role of environmental conditions on its development and to test new drugs.

Further testing is needed, but this approach potentially could improve treatment of a wide range of tumors that express COX - 2, particularly early - stage cancer.

Presentations included: Genetics Primer & Clinical Updates by Linford Williams, MS, LGC; Genetics and Women's Health: Seeing and Foreseeing the Ethical Challenges Ahead by Ruth Farrell, MD, MA; Preimplantation Genetic Screening and Diagnosis: What You Need to Know by Marissa Coleridge, MS, LGC; Evolution of Prenatal Genetic Screening and Testing: NIPT and Beyond by Jeff Chapa, MD, MBA; Promises and Pitfalls of Prenatal Whole Exome Sequencing by Amanda Kalan, MD; Fertility Preservation and Cancer: Survivors, Previvors, and the Newly Diagnosed by Rebecca Flyckt, MD; Improving Access to Cancer Genetics via Telegenetics by Ryan Noss, MS, LGC; Breast Cancer: Management of Moderate Penetrance Predisposition Genes by Holly Pederson, MD; Use of Hormonal and Non-hormonal Therapies in Breast Cancer Survivors and Women at High Risk for Breast / Gyn Cancers by Holly Thacker, MD; Addressing Commonly Asked Patient Questions about Genetics by Rebekah Moore, MS, LGC, Christina Rigelsky, MS, LGC and Allison Schreiber, MS, LGC; and a panel discussion on Genetic Testing Reimbursement featuring Bruce Rogen, MD, MPH and John Yao, MD, MBA, MPH, which was moderated by Daniel Sullivan, MD..

From testing new treatments, to improving drug combinations, our researchers are running clinical trials to ensure more people survive cancer.

The investigators are working to improve the test's ability to detect ovarian cancer.

Download our free eBook to learn more about an exciting new blood test that improves breast cancer detection.

November 23, 2015 New test may improve diagnosis and treatment of pancreatobiliary and other gastrointestinal cancers By collecting samples from the portal vein — which carries blood from the gastrointestinal tract, including from the pancreas, to the liver — physicians can learn far more about a patient's pancreatic cancer than by relying on peripheral blood from a more easily accessed vein in the arm.

The Biobanco - IMM allows the study of the pathogenesis of multiple diseases with enormous impact on human health (such as neurological diseases, rheumatic disorders and cancer), improving the identification of new prognostic and diagnostic tests and new therapeutic targets.

Overall, blood tests for prostate cancer activity improved and tumors shrunk.

Although the clinical data have provided some clarity regarding who should be screened, Krist said, they also show the need for a better screening test for prostate cancer and improved treatments.

In addition, the researchers further improved ovarian cancer detection rates to 63 percent by testing for tumor DNA in a patient's blood, alongside the DNA Pap test.

Silva says previous research suggests that screening behaviors for other types of cancer, including colorectal and cervical, have also improved since the ACA made preventive services (like colonoscopies and Pap tests) free for patients.

Foundation funded researchers recently found a genetic risk factor for this type of cancer in Haflinger horses, an important first step in developing improved diagnostic tests for this important cancer.

One Health wants to improve the treatment of canine cancer, using genomic testing and gene sequencing to improve diagnosis and the efficacy of treatments.

Passionately pursuing their mission to improve the lives of all patients afflicted with cancer, the people of Ventana discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare.

A2134 will restore essential funding for lifesaving, preventive services, including breast and cervical cancer, birth control, and testing and treatment for sexually transmitted infections, while A1656 will expand Medicaid coverage for reproductive health services to more New Jersey women, improving care and reducing unintended pregnancy in the state.